Showing 921-930 of 2159 results for "".
Filler Pearls: Refining the Art of Injection
https://practicaldermatology.com/topics/general-topics/filler-pearls-refining-the-art-of-injection/21683/Pain control is essential to treatment success with dermal fillers. Here's an update on pain management and other tactics to ensure patient comfort and optimize outcomes.Multiple Eruptive Myxoid Dermatofibromas in Patient With History of HIV
https://practicaldermatology.com/programs/practical-dermatology/multiple-eruptive-myxoid-dermatofibromas-in-patient-with-history-of-hiv/24216/Multiple eruptive dermatofibromas, a rare presentation of dermatofibroma, has been associated with altered immunity such as HIV/AIDS.The Role of Inflammation in Acne Vulgaris
https://practicaldermatology.com/topics/general-topics/the-role-of-inflammation-in-acne-vulgaris/21512/Multiple lines of evidence support a pivotal role for inflammation in the pathogenesis of acne vulgaris.What’s New in Topical Acne Treatment?
https://practicaldermatology.com/topics/acne-rosacea/whats-new-in-topical-acne-treatment/23277/Who Needs UV Education and Who Should Provide It?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/who-needs-uv-education-and-who-should-provide-it/20509/New recommendations from the United States Preventive Services Task Force seem to limit the PCP's role in patient UV education.DermWireTV: Derm Salaries Down, Allergan Eyes Soliton, Emsculpt Week
https://practicaldermatology.com/topics/practice-management/dermwiretv-derm-salaries-down-allergan-eyes-soliton-emsculpt-week/19941/Just under half of all physicians in the US are employed in physician-owned medical practices, new data from the American Medical Association show. Medscape’s annual Physician Compensation Report reveals that physicians overall saw a reduction in income due to the COVID-19 pandemic; income for dermDermWireTV: Sotyktu Approval, Cetaphil at 75, Psoriasis/Depression Link
https://practicaldermatology.com/topics/psoriasis/dermwiretv-sotyktu-approval-cetaphil-at-75-psoriasisdepression-link/20138/FDA has approved Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the oral treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. April Armstrong, MD discusses the first TYK-2 inhibitor approved for psoriasis. As Cetaphil (Galderma)BPO and Alternative Acne Options
https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/Acne treatments have been in the spotlight more than usual recently, as Valisure and the US Food and Drug Administration (FDA) have examined benzoyl peroxide (BPO) products for benzene contamination. At the same time, innovative new options are becoming available. Practical Dermatology spoke to DianDumbing Down of Dermatology By Evidence-Based Medicine
https://practicaldermatology.com/topics/practice-management/how-do-you-make-this-do-that/20593/Herbals in the Holistic Treatment of Psoriasis
https://practicaldermatology.com/topics/psoriasis/herbals-in-the-holistic-treatment-of-psoriasis/21055/Dermatologists must be aware of the herbal supplements patients may take and their potential effects.